Table 1 Characteristics of enrolled patients

Male (%)

7 (100)

Age (years)

62.1 ± 13.3

Dry weight (kg)

69.6 ± 17.8

Duration of diabetes (years)*

19 (12–40)

HD duration (months)*

1 (0.5–30)

Glucose level of dialysate, 125/150 mg/dL

5/2

Red blood cell (/μL)

355.3 ± 72.3

Hemoglobin concentration (g/dL)

10.3 ± 1.8

Hematocrit (%)

32.6 ± 4.9

Albumin concentration (g/dL)

3.8 ± 1.0

HbA1c (%)

6.8 ± 2.1

Glycated albumin (%)

24.7 ± 10.2

Fasting glucose level (mg/dL)

123.6 ± 80.4

Fasting C-peptide (ng/mL)*

3.70 (0.14–10.80)

Dietary treatment (kcal/IBWkg)

30.9 ± 2.4

ESA dosage (U/week)*

8000 (0–12,000)

Diabetic treatment, N

  Insulin + OHA/Insulin + GLP-1A/OHA alone

4/1/2

Diabetic neuropathy, −/ + 

0/7

Diabetic retinopathy, None/SDR/pre-PDR/PDR

2/0/0/5